Creation of the DRUGS-SAFER Centre


After five years of collaboration within the framework of the National Platform of Pharmacoepidemiology DRUGS-SAFE, the research partnership allowing the French Drug Agency (ANSM) to rely on the expertise of the BPH academic research teams is strengthening. This collaboration will now be conducted within the DRUGS-SAFER Centre, coordinated by the BPH Pharmacoepi team, and in partnership with the GIS EPI-PHARE created by the ANSM and the French Health Insurance System (CNAM). The DRUGS-SAFER Centre benefits from 4-year renewable funding.